Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
NYS Entity Status
NYS Filing Date
SEPTEMBER 17, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - 1000 MAIN STREET DEVELOPMENT II, LLC
AROUND THE WEB
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
- Bill and Hillary Clinton's Hamptons Summer Rental Sells
Tuesday Aug 29, 2017
In East Hampton, N.Y., the property was sold by real estate developer Elie Hirschfeld, president of Hirschfeld Properties.
- Near The East River, Plans Emerge For NY’s Next Life Science Center
By Ben Fidler - Monday Aug 21, 2017
At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]
- Street Fighter II
By Ars Staff - Monday Sep 4, 2017
Street Fighter II is an arcade monster that has stood the test of time.
- WD Navarre Holdings Files for Chapter 11 Protection
Friday Sep 8, 2017
WD Navarre Holdings LLC, the corporate parent of technology products distributor WYNIT Distribution LLC, filed for bankruptcy protection Friday.